|
|
Sangamo Therapeutics, Inc.
|
 |
||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
|
return to message board, top of board |
Re: AZN deal with Quell for Tregsthanks for sharing... AFAIK, that's the first deal since Merck acquired Pandion in Feb 2021 for $1.85B so AZN partnered with Quell for two indications with $85M upfront... that could be the catalyst for other BPs to start choosing their CAR-Tregs dance partners in rapid succession... per SM, there's now 15 (?) players in that sandbox Sangamo may be first-in-class... but let's see who BPs think are best-in-class... and as we all know, if ya snooze ya lose |
||||||||||||
|
|
return to message board, top of board |
| Msg # | Subject | Author | Recs | Date Posted |
| 173441 | Re: AZN deal with Quell for Tregs | rynotheknife | 5 | 6/9/2023 8:08:53 AM |
